No 04 2023

The ongoing struggle in the Nordic countries to keep prescription drug prices affordable without shutting out innovative, more expensive therapies continues to frustrate pharmaceutical companies as the introduction of new drugs to the region slows.

Quantum Foundry Copenhagen and the Novo Nordisk Foundation are building a 5,300m² quantum chip fabrication facility in Copenhagen, aiming to strengthen Europe's position in the global quantum race.

AAX Biotech AB won the prestigious Nordic Star Pitch Competition at the Nordic Life Science Days (NLSDays) 2026.

After a full career building life science communities and now approaching something akin to retirement – meaning only cherry-picking the projects that appeal to him – French-born Olivier Duchamp-Giudicelli reflects on the accidental advent of NLSDays in 2014, and how partnering and dealmaking have changed over the years.

In the phase 3 STEP Young trial, 40.4% of children aged 6 to under 12 treated with once-weekly semaglutide were no longer classified as having obesity after 68 weeks, compared with none of those on placebo.

Glycorex Transplantation has agreed a distribution deal with Grupo VIDA for its Glycosorb ABO technology in Brazil, as part of the Swedish medtech company's continued market expansion.

Our journalist Alexandra Hoegberg took the pulse of this year's NLSDays – the anticipation in the air, and the experiences and insights being shared.